Sheets Smith Wealth Management Has $878,000 Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Sheets Smith Wealth Management boosted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 3.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,005 shares of the company’s stock after acquiring an additional 218 shares during the period. Sheets Smith Wealth Management’s holdings in Addus HomeCare were worth $878,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the stock. American Century Companies Inc. boosted its position in shares of Addus HomeCare by 90.6% during the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after purchasing an additional 8,743 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. Amalgamated Bank increased its holdings in shares of Addus HomeCare by 8.4% in the second quarter. Amalgamated Bank now owns 5,330 shares of the company’s stock worth $619,000 after acquiring an additional 412 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of Addus HomeCare in the second quarter worth about $245,000. Finally, Sei Investments Co. raised its position in shares of Addus HomeCare by 22.2% during the second quarter. Sei Investments Co. now owns 13,770 shares of the company’s stock worth $1,599,000 after purchasing an additional 2,499 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Thursday, January 16th. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Stephens increased their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $133.67.

Addus HomeCare Trading Up 1.5 %

Shares of NASDAQ ADUS opened at $135.92 on Wednesday. The company has a market cap of $2.46 billion, a price-to-earnings ratio of 31.10, a PEG ratio of 1.74 and a beta of 1.00. The stock has a 50-day moving average price of $125.59 and a two-hundred day moving average price of $126.84. Addus HomeCare Co. has a 12 month low of $85.94 and a 12 month high of $136.68.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.03 EPS. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.